Skip to content

Implantable Electrode Leads 033-400, 402, and 436

by Telectronics, Inc.

510(k) K884278

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK884278 Date15 Dec 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

These devices are Permanent Pacemaker Electrodes, designed for implantation to facilitate cardiac pacing and rhythm monitoring. They deliver electrical impulses to stimulate the heart, ensuring proper cardiac function in patients with bradycardia or conduction disorders. The leads are configured for long-term use within pacemaker systems, providing reliable signal transmission between the heart and an external or implanted pulse generator.

Implantable Electrode Leads 033-400, 402, and 436 are sterile, single-use devices intended for surgical implantation by cardiologists in hospital or clinical settings. They are classified as Class III under FDA regulations (product code DTB) and require Premarket Approval or 510(k) clearance for compliance. Each lead model is uniquely identified by its reference code and must be stored under sterile conditions prior to use, adhering to manufacturer guidelines for handling and disposal.

Other devices from Telectronics, Inc.

See all devices from Telectronics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What are the primary clinical uses for these implantable electrode leads, and who should implant them?

    These leads are designed for permanent cardiac pacing and rhythm monitoring in patients with bradycardia or conduction disorders. They deliver electrical impulses to stimulate the heart, ensuring proper cardiac function. They should only be implanted by trained cardiologists in hospital or clinical settings during surgery, as they are sterile, single-use devices.

  • Are these leads reusable, and if not, how should they be handled before use?

    No, these leads are single-use devices and must remain sterile until implantation. They should be stored under sterile conditions prior to use, following the manufacturer’s guidelines for handling and disposal to maintain integrity and safety.

  • What regulatory pathway was followed for these leads, and which committee reviewed them?

    These leads were cleared via a Traditional 510(k) pathway under FDA regulations, classified as Class III (product code DTB). The review was conducted by the Cardiovascular (CV) Advisory Committee, with a decision of Substantially Equivalent (SESE) dated December 15, 1988.

  • How do I identify the correct lead model for my patient’s needs?

    Each lead model is uniquely identified by its reference code (033-400, 402, or 436). The selection should be based on the specific pacing requirements and anatomical considerations of the patient’s heart, as these leads are designed for long-term use within pacemaker systems to ensure reliable signal transmission.